Compare CNC & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CNC | ZTS |
|---|---|---|
| Founded | 1984 | 1952 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.1B | 31.9B |
| IPO Year | 2001 | 2012 |
| Metric | CNC | ZTS |
|---|---|---|
| Price | $67.42 | $74.76 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 16 | 12 |
| Target Price | $46.75 | ★ $154.18 |
| AVG Volume (30 Days) | 4.0M | ★ 5.3M |
| Earning Date | 04-28-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 1.86% |
| EPS Growth | N/A | ★ 10.05 |
| EPS | ★ 3.11 | 1.42 |
| Revenue | ★ $194,777,000,000.00 | $9,467,000,000.00 |
| Revenue This Year | $8.31 | $5.63 |
| Revenue Next Year | $1.05 | $4.77 |
| P/E Ratio | ★ $21.80 | $52.62 |
| Revenue Growth | ★ 19.44 | 2.28 |
| 52 Week Low | $25.08 | $71.47 |
| 52 Week High | $69.29 | $161.77 |
| Indicator | CNC | ZTS |
|---|---|---|
| Relative Strength Index (RSI) | 65.88 | 38.76 |
| Support Level | $33.27 | $74.35 |
| Resistance Level | N/A | $82.66 |
| Average True Range (ATR) | 2.17 | 2.51 |
| MACD | 0.03 | 0.17 |
| Stochastic Oscillator | 84.45 | 30.47 |
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 20 million medical members as of December 2025, mostly in Medicaid (about 64% of membership), the individual exchanges (about 28%), and Medicare (about 5%). The company also provides Medicare Part D pharmaceutical plans.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.